Efficacy and Safety of Slenyto for Insomnia in Children With ASD
Clinical trial NCT04233502 · WITHDRAWN
Trial details
- NCT number
- NCT04233502
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.